Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine β-synthase-deficient mice
Open Access
- 1 September 2000
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 279 (3) , H970-H975
- https://doi.org/10.1152/ajpheart.2000.279.3.h970
Abstract
Hyperhomocysteinemia is a risk factor for stroke, myocardial infarction, and venous thrombosis. Moderate hyperhomocysteinemia is associated with impaired endothelial function, but the mechanisms responsible for endothelial dysfunction in hyperhomocysteinemia are poorly understood. We have used genetic and dietary approaches to produce hyperhomocysteinemia in mice. Heterozygous cystathionine β-synthase-deficient mice (CBS +/−), which have a selective defect in homocysteine transsulfuration, and wild-type (CBS +/+) littermates were fed either a control diet or a diet that is relatively deficient in folic acid for 6 wk. Plasma total homocysteine was 5.3 ± 0.7 μM in CBS +/+ mice and 6.4 ± 0.6 μM in CBS +/− mice ( P = 0.3) given the control diet. Plasma total homocysteine was 11.6 ± 4.5 μM in CBS +/+ mice and 25.1 ± 3.2 μM in CBS +/− mice ( P = 0.004) given a low-folate diet. In mice fed the control diet, relaxation of aortic rings in response to the endothelium-dependent vasodilator acetylcholine did not differ significantly between CBS +/+ mice and CBS +/− mice. In contrast, in mice fed a low-folate diet, maximal relaxation to acetylcholine was markedly impaired in CBS +/− mice (58 ± 9%) compared with CBS +/+ mice (84 ± 4%) ( P = 0.01). No differences in relaxation to the endothelium-independent vasodilator sodium nitroprusside were observed among the four groups of mice. These data indicate that CBS-deficient mice are predisposed to hyperhomocysteinemia during dietary folate deficiency, and moderate hyperhomocysteinemia is associated with marked impairment of endothelial function in mice.Keywords
This publication has 34 references indexed in Scilit:
- Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic EvidenceAnnals of Internal Medicine, 1999
- Demonstration of Rapid Onset Vascular Endothelial Dysfunction After HyperhomocysteinemiaCirculation, 1999
- Hyperhomocysteinemia After an Oral Methionine Load Acutely Impairs Endothelial Function in Healthy AdultsCirculation, 1998
- Tissue Plasminogen Activator Binding to the Annexin II Tail DomainJournal of Biological Chemistry, 1998
- The metabolism of homocysteine: pathways and regulationEuropean Journal of Pediatrics, 1998
- Acute hyperhomocysteinaemia and endothelial dysfunctionThe Lancet, 1998
- Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Impaired relaxation of the carotid artery during activation of ATP-sensitive potassium channels in atherosclerotic monkeys.Stroke, 1994
- Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation.Journal of Clinical Investigation, 1992